Febuxostat 80 MG Oral Tablet — RxCUI 834241
RxNorm drug concept · Semantic clinical drug
RxCUI 834241
Semantic clinical drug · SCD
● Current RxNorm concept 41 FDA products
117 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI834241
Official nameFebuxostat 80 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped41
Package NDCs mapped117
Reported Medicaid activity (SDUD)30,153 prescriptions · 42 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Febuxostat: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- It lowers uric acid in adults with gout. It's meant for people who didn't respond to allopurinol, can't tolerate it, or can't use it. It isn't recommended if you have high uric aci...
- Take it by mouth once a day, with or without food or antacids. Your prescriber may adjust the dose after a couple of weeks based on your uric acid level. Follow your label closely.
- As uric acid drops, urate stored in your tissues is released, and that can trigger flares. It's common early on. Your doctor will likely recommend an NSAID or colchicine to help pr...
- Why did my gout flare up after I started?
🕸️ Concept Web — How Febuxostat 80 MG Oral Tablet Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Febuxostat 80 MG Oral Tablet
RxCUI 834241 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Febuxostat
73689IN
-
Febuxostat
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Uloric
834236BN
-
Uloric
-
Dose forms 9
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Febuxostat Oral Tablet
834234SCDF -
Febuxostat Oral Product
1163807SCDG -
Febuxostat Pill
1163808SCDG -
Febuxostat Oral Tablet [Uloric]
834238SBDF -
Uloric Oral Product
1187686SBDG -
Uloric Pill
1187687SBDG -
Oral Tablet
317541DF -
Oral Product
1151131DFG - +1 more in this family
-
Febuxostat Oral Tablet
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Febuxostat 80 MG
834240SCDC -
Febuxostat 80 MG Oral Tablet [Uloric]
834243SBD -
Febuxostat 80 MG [Uloric]
834242SBDC
-
Febuxostat 80 MG
Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Febuxostat 80 MG
SCDC · 834240 -
Febuxostat Oral Tablet
SCDF · 834234 -
Febuxostat Oral Product
SCDG · 1163807 -
Febuxostat Pill
SCDG · 1163808
Brand-Name Concepts
-
Febuxostat 80 MG Oral Tablet [Uloric]
SBD · 834243 -
Febuxostat 80 MG [Uloric]
SBDC · 834242 -
Febuxostat Oral Tablet [Uloric]
SBDF · 834238 -
Uloric Oral Product
SBDG · 1187686 -
Uloric Pill
SBDG · 1187687 -
Uloric
BN · 834236
📦 FDA Products & Package NDCs
41 products · 117 package NDCs
117 package NDCs map to RxCUI 834241 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00054-0413-13 | 30 TABLET in 1 BOTTLE (0054-0413-13) | Febuxostat | Hikma Pharmaceuticals USA Inc | 2019-11-11 |
| 00054-0414-13 | 30 TABLET in 1 BOTTLE (0054-0414-13) | Febuxostat | Hikma Pharmaceuticals USA Inc | 2019-11-11 |
| 00527-2244-32 | 30 TABLET in 1 BOTTLE (0527-2244-32) | FEBUXOSTAT | Lannett Company, Inc. | 2020-06-02 |
| 00527-2248-32 | 30 TABLET in 1 BOTTLE (0527-2248-32) | FEBUXOSTAT | Lannett Company, Inc. | 2020-06-02 |
| 00904-7395-46 | 30 TABLET, FILM COATED in 1 BOTTLE (0904-7395-46) | Febuxostat | MAJOR PHARMACEUTICALS | 2023-12-01 |
| 00904-7396-46 | 30 TABLET, FILM COATED in 1 BOTTLE (0904-7396-46) | Febuxostat | MAJOR PHARMACEUTICALS | 2023-12-01 |
| 00904-7484-03 | 30 TABLET, FILM COATED in 1 BOTTLE (0904-7484-03) | Febuxostat | Major Pharmaceuticals | 2024-05-22 |
| 00904-7485-03 | 30 TABLET, FILM COATED in 1 BOTTLE (0904-7485-03) | Febuxostat | Major Pharmaceuticals | 2024-05-22 |
| 16714-0059-01 | 30 TABLET, FILM COATED in 1 BOTTLE (16714-059-01) | Febuxostat | NorthStar RxLLC | 2021-01-26 |
| 16714-0060-01 | 30 TABLET, FILM COATED in 1 BOTTLE (16714-060-01) | Febuxostat | NorthStar RxLLC | 2021-01-26 |
| 27808-0206-01 | 30 TABLET in 1 BOTTLE (27808-206-01) | Febuxostat | Tris Pharma Inc | 2020-09-28 |
| 27808-0207-01 | 30 TABLET in 1 BOTTLE (27808-207-01) | Febuxostat | Tris Pharma Inc | 2020-09-28 |
| 33342-0274-07 | 30 FILM in 1 BOTTLE (33342-274-07) | Febuxostat | Macleods Pharmaceuticals Limited | 2019-04-04 |
| 33342-0274-10 | 90 FILM in 1 BOTTLE (33342-274-10) | Febuxostat | Macleods Pharmaceuticals Limited | 2019-04-04 |
| 33342-0274-15 | 500 FILM in 1 BOTTLE (33342-274-15) | Febuxostat | Macleods Pharmaceuticals Limited | 2019-04-04 |
| 33342-0275-07 | 30 FILM in 1 BOTTLE (33342-275-07) | Febuxostat | Macleods Pharmaceuticals Limited | 2019-04-04 |
| 33342-0275-10 | 90 FILM in 1 BOTTLE (33342-275-10) | Febuxostat | Macleods Pharmaceuticals Limited | 2019-04-04 |
| 33342-0275-15 | 500 FILM in 1 BOTTLE (33342-275-15) | Febuxostat | Macleods Pharmaceuticals Limited | 2019-04-04 |
| 43547-0295-03 | 30 TABLET in 1 BOTTLE (43547-295-03) | FEBUXOSTAT | Solco Healthcare US LLC | 2023-08-01 |
| 43547-0295-09 | 90 TABLET in 1 BOTTLE (43547-295-09) | FEBUXOSTAT | Solco Healthcare US LLC | 2023-08-01 |
| 43547-0295-50 | 500 TABLET in 1 BOTTLE (43547-295-50) | FEBUXOSTAT | Solco Healthcare US LLC | 2023-08-01 |
| 43547-0296-03 | 30 TABLET in 1 BOTTLE (43547-296-03) | FEBUXOSTAT | Solco Healthcare US LLC | 2023-08-01 |
| 43547-0296-09 | 90 TABLET in 1 BOTTLE (43547-296-09) | FEBUXOSTAT | Solco Healthcare US LLC | 2023-08-01 |
| 43547-0296-50 | 500 TABLET in 1 BOTTLE (43547-296-50) | FEBUXOSTAT | Solco Healthcare US LLC | 2023-08-01 |
| 46708-0190-08 | 80 TABLET, COATED in 1 CARTON (46708-190-08) | Febuxostat | Alembic Pharmaceuticals Limited | 2019-07-01 |
| 46708-0190-10 | 100 TABLET, COATED in 1 CARTON (46708-190-10) | Febuxostat | Alembic Pharmaceuticals Limited | 2019-07-01 |
| 46708-0190-30 | 30 TABLET, COATED in 1 BOTTLE (46708-190-30) | Febuxostat | Alembic Pharmaceuticals Limited | 2019-07-01 |
| 46708-0190-31 | 100 TABLET, COATED in 1 BOTTLE (46708-190-31) | Febuxostat | Alembic Pharmaceuticals Limited | 2019-07-01 |
| 46708-0190-91 | 1000 TABLET, COATED in 1 BOTTLE (46708-190-91) | Febuxostat | Alembic Pharmaceuticals Limited | 2019-07-01 |
| 46708-0191-06 | 60 TABLET, COATED in 1 CARTON (46708-191-06) | Febuxostat | Alembic Pharmaceuticals Limited | 2019-07-01 |
| 46708-0191-10 | 100 TABLET, COATED in 1 CARTON (46708-191-10) | Febuxostat | Alembic Pharmaceuticals Limited | 2019-07-01 |
| 46708-0191-30 | 30 TABLET, COATED in 1 BOTTLE (46708-191-30) | Febuxostat | Alembic Pharmaceuticals Limited | 2019-07-01 |
| 46708-0191-31 | 100 TABLET, COATED in 1 BOTTLE (46708-191-31) | Febuxostat | Alembic Pharmaceuticals Limited | 2019-07-01 |
| 46708-0191-91 | 1000 TABLET, COATED in 1 BOTTLE (46708-191-91) | Febuxostat | Alembic Pharmaceuticals Limited | 2019-07-01 |
| 47335-0721-13 | 500 TABLET, FILM COATED in 1 BOTTLE (47335-721-13) | Febuxostat | Sun Pharmaceutical Industries, Inc. | 2019-07-05 |
| 47335-0721-81 | 90 TABLET, FILM COATED in 1 BOTTLE (47335-721-81) | Febuxostat | Sun Pharmaceutical Industries, Inc. | 2019-07-05 |
| 47335-0721-83 | 30 TABLET, FILM COATED in 1 BOTTLE (47335-721-83) | Febuxostat | Sun Pharmaceutical Industries, Inc. | 2019-07-05 |
| 47335-0722-18 | 1000 TABLET, FILM COATED in 1 BOTTLE (47335-722-18) | Febuxostat | Sun Pharmaceutical Industries, Inc. | 2019-07-05 |
| 47335-0722-83 | 30 TABLET, FILM COATED in 1 BOTTLE (47335-722-83) | Febuxostat | Sun Pharmaceutical Industries, Inc. | 2019-07-05 |
| 47335-0722-88 | 100 TABLET, FILM COATED in 1 BOTTLE (47335-722-88) | Febuxostat | Sun Pharmaceutical Industries, Inc. | 2019-07-05 |
| 51407-0293-30 | 30 TABLET in 1 BOTTLE (51407-293-30) | Febuxostat | Golden State Medical Supply, Inc. | 2019-11-13 |
| 51407-0294-30 | 30 TABLET in 1 BOTTLE (51407-294-30) | Febuxostat | Golden State Medical Supply, Inc. | 2019-11-13 |
| 55111-0796-01 | 100 TABLET in 1 BOTTLE (55111-796-01) | Febuxostat | DR REDDY'S LABORATORIES LIMITED | 2020-11-25 |
| 55111-0796-05 | 500 TABLET in 1 BOTTLE (55111-796-05) | Febuxostat | DR REDDY'S LABORATORIES LIMITED | 2020-11-25 |
| 55111-0796-30 | 30 TABLET in 1 BOTTLE (55111-796-30) | Febuxostat | DR REDDY'S LABORATORIES LIMITED | 2020-11-25 |
| 55111-0796-90 | 90 TABLET in 1 BOTTLE (55111-796-90) | Febuxostat | DR REDDY'S LABORATORIES LIMITED | 2020-11-25 |
| 55111-0797-01 | 100 TABLET in 1 BOTTLE (55111-797-01) | Febuxostat | DR REDDY'S LABORATORIES LIMITED | 2020-11-25 |
| 55111-0797-05 | 500 TABLET in 1 BOTTLE (55111-797-05) | Febuxostat | DR REDDY'S LABORATORIES LIMITED | 2020-11-25 |
| 55111-0797-30 | 30 TABLET in 1 BOTTLE (55111-797-30) | Febuxostat | DR REDDY'S LABORATORIES LIMITED | 2020-11-25 |
| 55111-0797-90 | 90 TABLET in 1 BOTTLE (55111-797-90) | Febuxostat | DR REDDY'S LABORATORIES LIMITED | 2020-11-25 |
Observed labelers:
Viona Pharmaceuticals Inc (12) ·
Zydus Lifesciences Limited (12) ·
Alembic Pharmaceuticals Inc. (10) ·
Alembic Pharmaceuticals Limited (10) ·
Ascend Laboratories, LLC (8) ·
DR REDDY'S LABORATORIES LIMITED (8)
· +14 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.